Sequence Symmetry Analysis as a Signal Detection Tool for Potential Heart Failure Adverse Events in an Administrative Claims Database

Wahab IA 1 , Pratt NL 2 , Ellett LK 2 , Roughead EE 2

Affiliations 

  • 1 Faculty of Pharmacy, Cyberjaya University College of Medical Sciences, 3410, Jalan Teknokrat 3, Cyber 4, 63000, Cyberjaya, Selangor, Malaysia. izyan@cybermed.edu.my
  • 2 School of Pharmacy and Medical Sciences, Quality Use of Medicines and Pharmacy Research Centre, Sansom Institute, University of South Australia, Adelaide, SA, Australia
Drug Saf, 2016 Apr;39(4):347-54.
PMID: 26798053 DOI: 10.1007/s40264-015-0391-8

Abstract

The potential for routine sequence symmetry analysis (SSA) signal detection in health claims databases to detect new safety signals of medicines is unknown.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

MeSH terms
Similar publications